v3 Template
G

GelMEDIX

Biotechnology / Healthcare ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$13.0M
Funding Rounds
1
Last Funding
2026-02-17

About GelMEDIX

GelMEDIX, Inc. is focused on developing therapies to restore vision loss by regenerating damaged retinal cells and preserving essential structures for sight. Their mission is to leverage groundbreaking biomaterials technology to optimize the delivery, efficacy, and safety of cell and gene therapies, aiming to open new frontiers in treating degenerative eye diseases.

Products & Services

GMX-101:A retinal pigment epithelial (RPE) cell therapy designed to restore vision and halt disease progression in patients with late-stage Geographic Atrophy (GA), a major cause of irreversible blindness in adults over 60.
Regenerative Medicine Platform:A proprietary injectable hydrogel scaffold technology engineered to improve the functional replacement and integration of therapeutic cells and the delivery of gene therapies for degenerative eye diseases and other disorders.

Specialties

Biomaterials Engineering Regenerative Medicine Ophthalmology Cell and Gene Therapies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed
T: -
FT: Seed 		A: 13000000
MR: -
FA: 13 million
FAN: 13000000 		D: 2026-02-17
FD: 2026-02-17 		6 investors
Seed Latest
2026-02-17
$13.0M
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Max Cotler

Chief Executive Officer

LinkedIn (Pro only)
N

Noel Vera-Gonzalez

Chief Technology Officer

LinkedIn (Pro only)
A

Arthur Speros

Senior Research Associate

LinkedIn (Pro only)
N

Nasim Annabi

Co-Founder

M

Michael Cima

Independent Director

P

Purnanand Sarma

Strategic Advisor

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

GelMEDIX Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~150 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro